UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches

Molecular psychiatry, 2019-04, Vol.24 (4), p.576-587

2019

Volltextzugriff (PDF)

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2005-04, Vol.293 (13), p.1617

2005

Volltextzugriff (PDF)

Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis

Journal of rheumatology, 2000-11, Vol.27 (11), p.2635

2000

Volltextzugriff (PDF)

Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

Clinical pharmacology and therapeutics, 1999-03, Vol.65 (3), p.336-347

1999

Volltextzugriff (PDF)

Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia

The American journal of psychiatry, 2019-06, Vol.176 (6), p.457-467

2019

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia

The journal of clinical psychiatry, 2015-08, Vol.76 (8), p.1085-1090

2015

Volltextzugriff (PDF)

Relative bioavailability and safety of aripiprazole lauroxil, a novel once-monthly, long-acting injectable atypical antipsychotic, following deltoid and gluteal administration in adult subjects with schizophrenia

Schizophrenia research, 2014-11, Vol.159 (2), p.404-410

2014

Volltextzugriff (PDF)

Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2

Rheumatology (Oxford, England), 1999-08, Vol.38 (8), p.779-788

1999

Volltextzugriff (PDF)

Single- and Multiple-Dose Pharmacokinetics of Long-acting Injectable Naltrexone

Alcoholism, clinical and experimental research, 2006-03, Vol.30 (3), p.480-490

2006

Volltextzugriff (PDF)

Effect of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related Safety Considerations Among Patients With Acute Schizophrenia

The journal of clinical psychiatry, 2016-11, Vol.77 (11), p.1519-1525

2016

Volltextzugriff (PDF)

Response relationship of VAS and Likert scales in osteoarthritis efficacy measurement

Osteoarthritis and cartilage, 2003-07, Vol.11 (7), p.499-507

2003

Volltextzugriff (PDF)

The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis

Clinical therapeutics, 1999-10, Vol.21 (10), p.1688-1702

1999

Volltextzugriff (PDF)

Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia

International clinical psychopharmacology, 2016-03, Vol.31 (2), p.69-75

2016

Volltextzugriff (PDF)

A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder

The International journal of eating disorders, 2013-04, Vol.46 (3), p.239-245

2013

Volltextzugriff (PDF)

A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors

Inflammation research, 1996-02, Vol.45 (2), p.68-74

1996

Volltextzugriff (PDF)

Molecular Components of T-Cell Recognition

Annual review of immunology, 1992, Vol.10 (1), p.835-873

1992

Volltextzugriff (PDF)

Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors

Journal of rheumatology, 2001-11, Vol.28 (11), p.2494

2001

Volltextzugriff (PDF)

Dose-effect relationships of nonsteroidal anti-inflammatory drugs: a literature review

Clinical therapeutics, 2002-08, Vol.24 (8), p.1225-1291

2002

Volltextzugriff (PDF)

Pharmacokinetics of Long-Acting Naltrexone in Subjects With Mild to Moderate Hepatic Impairment

Journal of clinical pharmacology, 2005-11, Vol.45 (11), p.1259-1267

2005

Volltextzugriff (PDF)

Precision of composite measures of osteoarthritis efficacy in comparison to that of individual endpoints

Journal of rheumatology, 2001-12, Vol.28 (12), p.2700

2001

Volltextzugriff (PDF)

Subpixel edge location in binary images using dithering

IEEE transactions on pattern analysis and machine intelligence, 1995-06, Vol.17 (6), p.629-634

1995

Volltextzugriff (PDF)

T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen

The Journal of experimental medicine, 1993-08, Vol.178 (2), p.713-722

1993

Volltextzugriff (PDF)

Effect of rofecoxib therapy on measures of health-related quality of life in patients with osteoarthritis

The American journal of managed care, 2001-06, Vol.7 (6), p.609-616

2001

Volltextzugriff (PDF)

The nature of major histocompatibility complex recognition by γδ T cells

Cell, 1994, Vol.76 (1), p.29-37

1994

Volltextzugriff (PDF)

The nature of major histocompatibility complex recognition by gamma delta T cells

Cell, 1994-01, Vol.76 (1), p.29-37

1994

Volltextzugriff (PDF)

1 – 25 von 628

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(445)
Mit Volltextzugriff
(457)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis

Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia

A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia

Relative bioavailability and safety of aripiprazole lauroxil, a novel once-monthly, long-acting injectable atypical antipsychotic, following deltoid and gluteal administration in adult subjects with schizophrenia

Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2

Single- and Multiple-Dose Pharmacokinetics of Long-acting Injectable Naltrexone

Effect of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related Safety Considerations Among Patients With Acute Schizophrenia

Response relationship of VAS and Likert scales in osteoarthritis efficacy measurement

The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis

Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia

A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder

A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors

Molecular Components of T-Cell Recognition

Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors

Dose-effect relationships of nonsteroidal anti-inflammatory drugs: a literature review

Pharmacokinetics of Long-Acting Naltrexone in Subjects With Mild to Moderate Hepatic Impairment

Precision of composite measures of osteoarthritis efficacy in comparison to that of individual endpoints

Subpixel edge location in binary images using dithering

T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen

Effect of rofecoxib therapy on measures of health-related quality of life in patients with osteoarthritis

The nature of major histocompatibility complex recognition by γδ T cells

The nature of major histocompatibility complex recognition by gamma delta T cells

Suchergebnisse filtern